Although the vascular access repair products market continues to be dominated by two multinationals, St. Jude Medical Inc. and Abbott Vascular/Abbott Laboratories Inc., their share will be eroded over the next five years. Innovative products from newer competitors, such as AccessClosure Inc., are gaining acceptance from interventionalists and the emerging Asian markets in particular are seeing an uptake in the use of higher-tech devices and the emergence of local manufacturers.
According toVascular Control Systems Inc., a division of Johnson & Johnson’s Ethicon Inc. that is developing vascular access closure products, there are more than 12 million endovascular procedures performed annually that require percutaneous access, primarily through the femoral artery. These vascular access punctures require rapid closure and careful management immediately following the procedure
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?